Skip to content

Teriparatide (Forteo)

Also known as PTH 1-34 and Forteo.

On the market for two decades as an approved osteoporosis medicine. A bone-cancer signal in rodents has been neither confirmed nor fully ruled out in people.

SerValSerGluIleGlnLeuMetHisAsnLeuGlyLysHisLeuAsnSerMetGluArgValGluTrpLeuArgLysLysLeuGlnAspValHisAsnPhe
34 amino acids, in order. End caps, bridges and anything attached to the chain are not drawn. Source: PubChem.
Human evidence
Grade A

Large trials

Completed randomized trials
5+

The plus sign marks a floor: the record counts more trials than it lists.

Approved?
US and EU

Approved in the US and the EU

Sport (WADA)
Not named

Not named on WADA's list. That is not clearance.

Checked on .

How we count a trial
Short answer

As of September 2026, teriparatide is an approved medicine for osteoporosis in the US and the EU. The FDA approved it in 2002 as Forteo, and the EMA in 2003 as Forsteo. A bone-cancer signal seen in rodents has been neither confirmed nor fully ruled out in people. If a vial of teriparatide reached you outside a pharmacy, you cannot tell from the outside what it holds.

Get an email when the teriparatide record changes.

You get the Wednesday email. When this record changes, the subject line says so. Unsubscribe anytime. Privacy

What is teriparatide?

Teriparatide is a lab-made version of the first 34 amino acids of human parathyroid hormone, which regulates calcium and bone metabolism. Eli Lilly developed it. The FDA approved it in 2002 and the EMA in 2003, based on fracture-prevention trials, and biosimilars, close copies of it, have been approved since.

Does teriparatide work?

The FDA and the EMA reviewed the trials and approved it for osteoporosis. The record names three groups: postmenopausal women, men at high fracture risk, and people with glucocorticoid-induced osteoporosis.

What we found. 5+ completed randomized trials counted on the record. 3 study rows listed below, and one of them is a pooled analysis, so the number shows with a plus sign until every trial is listed.

Studies on the teriparatide record: each study, what it was tested in, its status and what it shows.
Fracture Prevention Trial (Neer and colleagues)PeoplePublished. The basis for the 2002 approvalFewer spine fractures and fewer non-spine fractures than placebo
Teriparatide or alendronate in glucocorticoid-induced osteoporosis (NEJM)PeoplePublishedBone density rose more with teriparatide than with alendronate in this group
Meta-analysis of teriparatide and lumbar spine bone densityPeoplePublishedAcross the pooled trials, a consistent benefit in bone density and in fracture reduction
How we count a trial

Is teriparatide safe?

The record describes a long human safety record. The open question comes from animals: a bone-cancer signal, osteosarcoma, seen only in rodents. Long-term tracking in people has neither confirmed it nor fully ruled it out, despite two decades on the market. The record says that signal is behind the label's boxed warning and its limit on treatment time. That is the picture for the approved products. A vial with no pharmacy behind it comes next.

What is in a vial sold as teriparatide?

The Fracture Prevention Trial was the basis for the 2002 approval of Forteo, Eli Lilly's product. This record holds no sign of teriparatide sold outside pharmacies. If a vial came to you another way, no trial on this page covers it. The checklist lists what to ask the seller.

What don't we know?

  • Whether the bone-cancer signal seen in rodents applies to people. Two decades of use have not settled it.
  • Whether the label's limit on treatment time could be relaxed. The record ties that to long-term registry data.
  • What is in any vial that did not come from a pharmacy.

The other side

Teriparatide comes with a prescription and a doctor's care, and the record describes a long track record of clinical use. The biggest open question on this page concerns a signal seen only in rodents.

What would change this record?

  • Large, long-running registry data, gathered after approval, that confirm no osteosarcoma signal in people. The record says this could support relaxing the limits on how long the medicine is used.

Change log

  • Record checked. No change logged yet.
Every change on the Table

Three questions to ask next

Ask better questions.

More questions about teriparatide

Is teriparatide the same as Forteo?

Forteo is the brand name the FDA approved in 2002. The EMA approved it in 2003 as Forsteo, and biosimilar versions have been approved since.

Is teriparatide the same as PTH 1-34?

Yes. PTH 1-34 is another name for it. Teriparatide is a lab-made version of the first 34 amino acids of human parathyroid hormone, or PTH.

What is teriparatide approved for?

Osteoporosis, in the US and the EU. The record names postmenopausal women, men at high fracture risk, and people with glucocorticoid-induced osteoporosis.

Does teriparatide cause bone cancer in people?

That has been neither confirmed nor fully ruled out. The signal was seen only in rodents, and two decades of use have not settled it for people.

Is teriparatide the same as abaloparatide?

No. Teriparatide copies part of parathyroid hormone. Abaloparatide mimics part of another protein, PTHrP.
Sources

Record checked on . Each source shows the date it was checked.

Still curious

Have a question about teriparatide?

Ask us directly. We answer from sources we can link. We cannot answer dosing, sourcing or personal medical questions.